Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.21 - $39.48 $1.01 Million - $1.46 Million
-37,093 Reduced 96.01%
1,543 $44,000
Q4 2023

Feb 14, 2024

SELL
$21.2 - $31.03 $164,999 - $241,506
-7,783 Reduced 16.77%
38,636 $1.18 Million
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $3.16 Million - $4.35 Million
-120,636 Reduced 72.21%
46,419 $1.25 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $41.38 $4.2 Million - $6.91 Million
167,055 New
167,055 $5.96 Million
Q4 2021

Feb 14, 2022

SELL
$58.09 - $82.51 $2.43 Million - $3.45 Million
-41,803 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $890,236 - $1.3 Million
15,249 Added 57.43%
41,803 $2.61 Million
Q2 2021

Aug 16, 2021

SELL
$62.15 - $90.32 $293,285 - $426,220
-4,719 Reduced 15.09%
26,554 $2.2 Million
Q1 2021

May 17, 2021

SELL
$61.35 - $90.47 $248,344 - $366,222
-4,048 Reduced 11.46%
31,273 $2.07 Million
Q4 2020

Feb 16, 2021

BUY
$43.82 - $85.37 $1.55 Million - $3.02 Million
35,321 New
35,321 $2.71 Million
Q2 2020

Aug 14, 2020

SELL
$26.12 - $43.27 $208,960 - $346,160
-8,000 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$20.56 - $63.12 $123,359 - $378,720
-6,000 Reduced 42.86%
8,000 $230,000
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $393,960 - $1.02 Million
14,000 New
14,000 $888,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.